TSXV/SHRX (TSXV/SHRX)

TSX Venture Exchange: TSXV/SHRX · CAD

CA$1.37

+0.00 (0.0%)· Recorded snapshot

Market cap	43.3M
Net income (ttm)	-7.4M
EPS (ttm)	-CA$0.25
Shares out	31.6M
Volume	0
Beta	-1.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.4M
EPS (ttm): -CA$0.25
Market cap: 43.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3,762.2

P25 n/aP50 n/aP75 n/a

ROIC-180.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/SHRX indicators

Market & fundamental data

Available fields

118

Groups with data

Currency

USD

Showing 118 of 118 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-26
Enterprise value	CAD 46.3M
Exchange	TSX Venture Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA8200092077
Last earnings date	2025-11-28
Last refreshed	2026-10-28
Last stock split date	2025-01-27
Last stock split type	Reverse
Market cap	CAD 43.3M
Next earnings date	2026-11-26
Price	CAD 1.37
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-09-21
Symbol	tsxv/SHRX
Website	https://sharptx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-17.91%
FCF / EV yield	-13.3%
FCF yield	-14.24%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-131.63%
ROCE	482.61%
ROE	-3,762.21%
ROIC	-180.75%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD -47,712
EBIT	CAD -7.9M
EBITDA	CAD -7.9M
EPS	CAD -0.25
FCF per share	CAD -0.20
Financing cash flow	CAD 2M
Free cash flow	CAD -6.2M
Free cash flow minus SBC	CAD -7.1M
Net borrowing	CAD 1.9M
Net cash flow	CAD -4.3M
Net income	CAD -7.4M
Operating cash flow minus SBC	CAD -7.1M
Operating income	CAD -7.9M
Stock-based compensation	CAD 906,002

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.10
Interest coverage	-33.77
Long-term assets	CAD 1.3M
Long-term liabilities	CAD 1.5M
Net cash (debt)	CAD -3.1M
Net cash / market cap	-7.07%
Piotroski F-Score	1
Property, plant and equipment	CAD 1.2M
Shareholders' equity	CAD -3.1M
Tangible book value	CAD -3.1M
Tangible book value per share	CAD -0.10
Total assets	CAD 1.5M
Total cash	CAD 148,652
Total debt	CAD 3.2M
Total liabilities	CAD 4.6M
WACC	-1.5%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 209,865
Current liabilities	CAD 3.1M
Current ratio	0.07
Net working capital	CAD -1.3M
Quick ratio	0.05
Working capital	CAD -2.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-28.61%
Shareholder yield	-28.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	50.55%
1M total return	50.55%
1Y price change	174%
1Y return CAGR	174.19%
1Y total return	174%
20-day SMA	CAD 2.10
3M price change	37%
3M total return	37%
50-day SMA	CAD 2.86
52-week high	CAD 5.00
52-week high date	2025-11-06
52-week low	CAD 0.23
52-week low date	2025-10-03
6M price change	-39.11%
6M total return	-39.11%
All-time high	CAD 5.00
All-time high date	2025-11-06
All-time low	CAD 0.23
All-time low date	2025-10-03
Average true range (ATR)	CAD 0.26
Average volume	3.5K
Beta (1Y)	-0.88
Beta (2Y)	-2.94
Beta (5Y)	-1.14
Change from 52-week high	-72.6%
Change from 52-week low	495.65%
Change from all-time high	-72.6%
Change from all-time low	495.65%
Monthly RSI	39.82
Previous close	CAD 1.37
Price vs 20-day SMA	-34.67%
Price vs 50-day SMA	-52.06%
Relative volume	0.06
RSI	35.22
Sharpe ratio	1.07
Sortino ratio	2.08
Volume	0
Weekly RSI	47.93
YTD price change	-45.2%
YTD total return	-45.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17.6M
Shares change (QoQ)	0%
Shares change (YoY)	28.61%
Shares held by insiders	4.18%
Shares held by institutions	0.67%
Shares outstanding	31.6M

Deeper analysis on TSXV/SHRX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/SHRX report

Is a complete TSXV/SHRX research report available?

No complete published report is available for tsxv/SHRX (TSXV/SHRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/SHRX (TSXV/SHRX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/SHRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/SHRX indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/SHRX

Frequently asked questions